Ali Shilatifard, a prominent figure in biochemistry and molecular genetics, has been elected to the National Academy of Sciences. Recognized for his contributions to epigenetics and chromatin biology, his research sheds light on childhood leukemia and transcription processes. His recent findings link epigenetic mechanisms to cancer, paving the way for innovative treatments. Shilatifard expresses gratitude for his team and Northwestern University, acknowledging their support in his scientific journey. His election reaffirms his role as a leader in advancing our understanding of cancer and epigenetics.
Ali is a visionary leader in the fields of epigenetics and chromatin biology, and this well-deserved honor further solidfies his status as a scientific pioneer.
Working as a biochemist in the field of pediatric cancer has been one of the most meaningful experiences and has given me a deep appreciation for how precious, fragile and intricate life truly is.
This recognition would not be possible without the dedication and brilliance of my lab team - past and present - whose tireless pursuit of truth and discovery continues to inspire me every day.
Studies from Shilatifard's laboratory linking epigenetic factors and transcription elongation control to malignancies have provided new therapeutic approaches for cancer treatment.
Collection
[
|
...
]